Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 201817002543
Who filed: The Delhi Network of Positive People
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 02-10-2021
Patent type: Combination

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)

Countries: India Date: 2021
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)

Countries: India Date: 2021
Delhi Network of Positive People opposition, GSK3036656, (201717032083)

Countries: India Date: 2021
Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (201627039572)

Countries: India Date: 2018
Delhi Network of Positive People (DNP+) opposition, Sofosbuvir/Velpatasvir, (201627008488)

Countries: India Date: 2018
Delhi Network of Positive People (DNP+) opposition, Lumacaftor, (3158/KOLNP/2012)

Countries: India Date: 2021
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)

Countries: India Date: 2021
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2014
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Velpatasvir, (PCT/US2012/065681 (4351/DELNP/2013))

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))

Countries: India Date: 2017